Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Nuclear Regulatory Commission

This article was originally published in The Gray Sheet

Executive Summary

Nuclear Regulatory Commission: Advisory committee on the medical uses of isotopes is slated to meet April 10-11 in Rockville, Maryland to discuss the commission's staff requirements memorandum "Materials/Medical Oversight (DSI 7)"; its medical policy statement of 1979; criteria and ranking of medical procedures by risk; regulatory use of the advisory committee process; and status reports on proposed rulemaking and guidance documents." On April 11, the committee will also prepare for a May 15 meeting with the commissioners. For more information, contact NRC's William McCarthy at 301/415-7900...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT007819

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel